Pharmaids Pharmaceuticals Quarterly Results for Trading Insights
PHARMAID • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-3 Cr
QSept 2025
Pharmaids Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹12 Cr in Sept 2025 (+140.0% vs Mar 2025, +140.0% vs Sept 2024)
- Net Profit of ₹-3 Cr in Sept 2025 (+40.0% vs Mar 2025, -50.0% vs Sept 2024)
- EBITDA of ₹-2 Cr in Sept 2025 (+50.0% vs Mar 2025)
- Operating Margin of -62.0% in Sept 2025 (+20.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.70 in Sept 2025 (+36.9% vs Mar 2025)
Pharmaids Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 12 | 5 | 7 | 5 | 6 | 140.0% | 140.0% |
| Net Profit (₹ Cr) | -3 | -5 | -5 | -2 | -6 | - | - |
| EBITDA (₹ Cr) | -2 | -4 | -5 | -2 | -6 | - | - |
| EPS (₹) | -0.70 | -1.11 | -1.39 | -0.73 | -2.82 | - | - |
| Operating Margin (%) | -62.0% | -82.0% | -81.0% | -46.0% | -96.0% | - | - |
Pharmaids Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Pharmaids Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Pharmaids Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Pharmaids Pharmaceuticals
Additional stock information and data for PHARMAID
Revenue Trend (₹ Cr)
Sept 2024
5
Jun 2025
7
Mar 2025
5
Sept 2025
12
Net Profit Trend (₹ Cr)
Sept 2024
-2
Jun 2025
-5
Mar 2025
-5
Sept 2025
-3
Operating Margin Trend (%)
Sept 2024
-46.0%
Jun 2025
-81.0%
Mar 2025
-82.0%
Sept 2025
-62.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Pharmaids Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores